Director, Key Account Management

Company Overview

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double‑stranded breaks in the DNA.

This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values‑driven organization committed to its people, cutting‑edge science, and a vision of providing life‑long cures to patients suffering from serious diseases.

The Director, Key Account Management (KAM) is the primary commercial liaison between Beam Therapeutics and its network of Authorized Treatment Centers (ATCs). The KAM is accountable for end‑to‑end account performance — from site qualification and onboarding through sustained therapy utilization — and serves as the field‑based lead of the cross‑functional pod (Medical Affairs, Clinical Operations, Market Access, Quality, and Marketing). This is a high‑impact individual contributor role requiring strategic account planning, executive‑level relationship building, and disciplined tactical execution.

We are actively hiring for several positions across regions nationwide.

• Evaluate site capabilities, patient volume, and infrastructure; develop findings into structured readiness reports.
• Serve as the commercial liaison for site contracting and activation activities.
• Own account‑level performance against activation timelines and operational milestones; escape barriers with proposed solutions.

• Serve as the primary point of contact for commercial and operational matters at assigned ATCs.
• Maintain living account profiles and strategic account plans, updated quarterly and aligned to brand strategy.
• Engage senior institutional leadership in strategic conversations about the value and operational integration of Beam’s therapies.

• Serve as the commercial anchor of the account‑level field pod, aligning the activities of Medical Affairs, Clinical Operations, Market Access, and Marketing partners.

• Drive appropriate, label‑compliant therapy utilization within assigned accounts, consistently meeting or exceeding demand targets.
• Analyze account performance to identify utilization trends, referral gaps, and opportunities to optimize pathway efficiency.
• Represent Beam at national and regional conferences, including Thought Leader engagement and reporting on relevant sessions.

• Bachelor’s degree required; advanced degree (MBA, PharmD, MPH, or scientific graduate degree) preferred.
• Minimum 10+ years of pharmaceutical/biotech commercial experience, with 5+ years in cell/gene therapy or complex specialty hematology/oncology preferred.
• Willingness to travel up to 50% to support site visits, conferences, and on‑site activities including staff training and operational planning.

• Deep knowledge of hematology and sickle cell disease.
• Comprehensive understanding of the cell and gene therapy landscape.
• Ability to engage credibly with academic specialists, advanced practice providers, and multidisciplinary care teams.

• Track record of managing large, complex academic medical centers or integrated health systems, including navigating institutional hierarchies and long sales cycles.
• Documented sales achievement in specialty biopharmaceuticals, rare disease, or cell/gene therapy, with consistent attainment of demand, activation, and utilization targets.
• Experience developing and executing insight‑driven account plans that align site capabilities with brand objectives.
• Proven ability to lead cross‑functional field teams…